<DOC>
	<DOCNO>NCT00364689</DOCNO>
	<brief_summary>The purpose study compare effectiveness three different treatment hepatic encephalopathy . These treatment : - Group 1 - lactulose give rifaximin placebo ( sugar pill ) - Group 2 - lactulose give rifaximin - Group 3 - rifaximin give alone The goal study determine treatment effective ( 1 ) reduce admission hospital hepatic encephalopathy ( 2 ) improve mental function , study period .</brief_summary>
	<brief_title>RICE Trial : Rifaximin In Chronic Hepatic Encephalopathy - A Randomized , Controlled Trial</brief_title>
	<detailed_description>Background : Hepatic encephalopathy ( HE ) reversible process result advanced liver disease . It range severity disturb sleep pattern profound coma trigger number common factor , include intestinal bleeding , infection , constipation , dietary change . This study compare two different medication , use alone combination , prevent relapse HE . Lactulose laxative ( cause increase bowel movement ) widely use treatment HE . However , clear effective purpose always well tolerate . Rifaximin oral antibiotic study treatment HE , include longer treatment course role prevention HE relapse clear . No study date compare use lactulose combination treatment lactulose rifaximin prevention recurrent episode HE . Study Overview : This study single-center , randomize , control trial evaluate efficacy safety rifaximin , give alone combination lactulose , compare lactulose give alone , subject remission prior acute episode HE . This study seek specifically examine role combination treatment rifaximin lactulose , compare either treatment alone , maintain remission HE . Our study hypothesis rifaximin , give alone combination lactulose , reduce number hospital admission acute HE , improve overall mental function treatment period , relative standard lactulose therapy . This double-blinded study ( rifaximin ) , mean neither study doctor know whether treated rifaximin placebo pill . You , however , know whether receive lactulose .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Cirrhosis cause History previous admission acute HE within 1 year screen History allergy lactulose rifaximin . Ongoing alcohol drug dependence Required use sedative narcotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Encephalopathy , Hepatic</keyword>
	<keyword>Portosystemic Encephalopathy</keyword>
	<keyword>Encephalopathy , Hepatocerebral</keyword>
	<keyword>Encephalopathy , Portal-Systemic</keyword>
	<keyword>Encephalopathy , Portosystemic</keyword>
	<keyword>Hepatic Coma</keyword>
	<keyword>Hepatic Stupor</keyword>
	<keyword>Hepatocerebral Encephalopathy</keyword>
	<keyword>Portal-Systemic Encephalopathy</keyword>
</DOC>